ChanRx Closes Series A to Advance Atrial Fib Drug
By Marie Powers
Wednesday, November 23, 2011
ChanRx Corp., launched in 2006 as a spinoff from Cleveland-based pharmaceutical testing company ChanTest Corp., closed a Series A financing with investments from Sante Ventures, of Austin, Texas, and company founder and chairman Arthur "Buzz" Brown.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.